{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:27:31Z","timestamp":1787840851307,"version":"build-2784847793"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lung squamous cell carcinoma (LUSC) is the dominant histological subtype of lung cancer, accounting for 30% of all cases. Most patients develop distant metastases by the time they are diagnosed with the disease, owing to a delay in the appearance of symptoms. Therefore, accurate prognostic prediction is essential for personalized treatment. However, existing models tend to ignore competing risks, leading to an overestimation of the incidence. This study aimed to construct an accurate mortality risk prediction model for LUSC patients from the perspective of competing risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 28,312 patients with LUSC from 2000 to 2019 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Potential predictors included age, sex, treatments, race, marital status, tumor site, differentiation, and stage. Statistical analyses were performed using cause-specific hazard and Fine\u2013Gray risk models to assess competing risks. Model performance was evaluated using Harrell\u2019s concordance index and calibration plots.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Age, sex, treatment, marital status, tumor site, differentiation, and stage significantly affected the prognosis of LUSC. Both risk models showed good predictive power. The Fine\u2013Gray risk model was slightly better than the cause-specific hazard model in terms of the 3- and 5-year mortality. The key risk factors for LUSC outcomes included age, male gender, absence of surgery, chemotherapy or radiotherapy, being unmarried or divorced, primary tumors in the lower lobe or main bronchus, low differentiation, and high tumor stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The Fine\u2013Gray model excels in predicting LUSC death risk and holds significant clinical value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_791_25","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:06:43Z","timestamp":1756998403000},"page":"810-817","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Construction and application of a mortality risk prediction model for patients with lung squamous cell carcinoma: A competing risk analysis"],"prefix":"10.4103","volume":"21","author":[{"given":"Qin","family":"Wang","sequence":"first","affiliation":[{"name":"School of Public Health, Shandong Second Medical University, Weifang, China"},{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Public Health, Shandong Second Medical University, Weifang, China"},{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Data Science, School of Statistics and Mathematics, Shandong University of Finance and Economics, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Lao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Data Open Innovative Application Laboratory, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Data Science, School of Statistics and Mathematics, Shandong University of Finance and Economics, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"R1-20250905","first-page":"229","article-title":"Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20250905","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R3-20250905","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3892\/mco.2021.2410","article-title":"Lung cancer, treatment and nutritional status","volume":"15","author":"Pilikidou","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"R4-20250905","doi-asserted-by":"crossref","first-page":"992990","DOI":"10.3389\/fimmu.2022.992990","article-title":"Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma","volume":"13","author":"Shi","year":"2022","journal-title":"Front Immunol"},{"key":"R5-20250905","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4103\/jcrt.jcrt_2352_22","article-title":"Prediction of lymph node metastasis of lung squamous cell carcinoma by machine learning algorithm classifiers","volume":"19","author":"Li","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R6-20250905","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ccell.2022.09.018","article-title":"Squamous cell lung cancer:Current landscape and future therapeutic options","volume":"40","author":"Lau","year":"2022","journal-title":"Cancer Cell"},{"key":"R7-20250905","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ijc.32532","article-title":"A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis","volume":"146","author":"Hata","year":"2020","journal-title":"Int J Cancer"},{"key":"R8-20250905","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/sim.4384","article-title":"Competing risks and the clinical community:Irrelevance or ignorance?","volume":"31","author":"Koller","year":"2012","journal-title":"Stat Med"},{"key":"R9-20250905","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021:A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R10-20250905","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/RLU.0000000000003739","article-title":"Prognostic significance of pretreatment staging with 18F-FDG PET in esophageal cancer:A nationwide population-based study","volume":"46","author":"Lu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R11-20250905","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/10543409708835206","article-title":"A reviewer's perspective on multiple endpoint issues in clinical trials","volume":"7","author":"Huque","year":"1997","journal-title":"J Biopharm Stat"},{"key":"R12-20250905","doi-asserted-by":"crossref","first-page":"1073274821989316","DOI":"10.1177\/1073274821989316","article-title":"Competitive risk analysis of prognosis in patients with cecum cancer:A population-based study","volume":"28","author":"Wu","year":"2021","journal-title":"Cancer Control"},{"key":"R13-20250905","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"R14-20250905","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12885-020-06927-w","article-title":"A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Cancer"},{"key":"R15-20250905","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1272\/jnms.JNMS.2020_86-610","article-title":"Nomograms to predict survival in patients with lung squamous cell cancer:A population-based study","volume":"86","author":"Zheng","year":"2019","journal-title":"J Nippon Med Sch"},{"key":"R16-20250905","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12967-020-02606-3","article-title":"A prognostic model for elderly patients with squamous non-small cell lung cancer:A population-based study","volume":"18","author":"Chen","year":"2020","journal-title":"J Transl Med"},{"key":"R17-20250905","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2019.12.007","article-title":"Survival disparities following surgery among patients with different histological types of non-small cell lung cancer","volume":"140","author":"Grosu","year":"2020","journal-title":"Lung Cancer"},{"key":"R18-20250905","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/jcrt.jcrt_2036_23","article-title":"Pattern and trend of cancer in Saurashtra region in Gujarat state of India, a hospital-based study","volume":"20","author":"Saini","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R19-20250905","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5761\/atcs.oa.17-00020","article-title":"Difference in postsurgical prognostic factors between lung adenocarcinoma and squamous cell carcinoma","volume":"23","author":"Nakamura","year":"2017","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R20-20250905","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1158\/1078-0432.CCR-11-2370","article-title":"Squamous cell carcinoma of the lung:Molecular subtypes and therapeutic opportunities","volume":"18","author":"Perez-Moreno","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R21-20250905","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CM9.0000000000001802","article-title":"Primary tumour location in lung cancer:The evaluation and administration","volume":"135","author":"Xie","year":"2021","journal-title":"Chin Med J"},{"key":"R22-20250905","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2169\/internalmedicine.1005-22","article-title":"Left main bronchus obstruction in a patient with small-cell lung cancer successfully treated with venovenous extracorporeal membrane oxygenation","volume":"63","author":"Nagai","year":"2024","journal-title":"Intern Med"},{"key":"R23-20250905","first-page":"e918686","article-title":"A competing risk analysis study of prognosis in patients with esophageal carcinoma 2006\u20132015 using data from the surveillance, epidemiology, and end results (SEER) database","volume":"26","author":"Yu","year":"2020","journal-title":"Med Sci Monit"},{"key":"R24-20250905","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics:Competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"key":"R25-20250905","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/eurheartj\/ehu131","article-title":"Competing risks analyses:Objectives and approaches","volume":"35","author":"Wolbers","year":"2014","journal-title":"Eur Heart J"},{"key":"R26-20250905","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-11-2097","article-title":"The use and interpretation of competing risks regression models","volume":"18","author":"Dignam","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R27-20250905","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2188\/jea.JE20240063","article-title":"Rare event approximation between subdistribution hazard ratio and cause-specific hazard ratio in survival analysis with competing risks","volume":"34","author":"Tanaka","year":"2024","journal-title":"J Epidemiol"},{"key":"R28-20250905","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1002\/sim.9023","article-title":"Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types:Cumulative total failure probability may exceed 1","volume":"40","author":"Austin","year":"2021","journal-title":"Stat Med"},{"key":"R29-20250905","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11864-002-0045-9","article-title":"Elderly patients with lung cancer:Biases and evidence","volume":"3","author":"Langer","year":"2002","journal-title":"Curr Treat Options Oncol"},{"key":"R30-20250905","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.rcl.2012.06.006","article-title":"Lung cancer epidemiology, risk factors, and prevention","volume":"50","author":"De","year":"2012","journal-title":"Radiol Clin North Am"},{"key":"R31-20250905","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4103\/jcrt.jcrt_1431_22","article-title":"KRAS and BRAF genetic alterations in lung cancer:A case - control study","volume":"20","author":"Sawal","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R32-20250905","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1038\/s41598-024-57814-4","article-title":"The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Sci Rep"},{"key":"R33-20250905","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.21037\/atm-21-4470","article-title":"An integrated model of FTO and METTL3 expression that predicts prognosis in lung squamous cell carcinoma patients","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_791_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:30:39Z","timestamp":1787837439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_791_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_791_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}